Guild hails allergy strategy
August 10, 2015
The Pharmacy Guild of Australia
has welcomed the release of the
National Allergy Strategy, the first
comprehensive Australian initiative
aiming to improve the assessment
and treatment of allergic diseases
which affect more than four million
or almost 20% of the population.
As the fastest growing chronic
disease and public health issue
in Australia, allergic diseases can
range from food, insect and drug
allergies (including anaphylaxis)
through to asthma, allergic rhinitis
(hay fever) and eczema, said the
Guild.
Pharmacy can play a key role in
allergy treatment, especially in
the shared care model of practice,
highlighting the importance of
improved communication between
pharmacists, GPs and clinical
immunology/allergy specialists.
The strategy states that the
“services of dietitians, pharmacists
and psychologists in particular,
are often required to optimally
manage allergic diseases” and
emphasises the need to promote
referral to allied health professionals
with expertise in allergy, such as
pharmacists, who provide self care
and quality use of medicines advice.
The National Allergy Strategy
was developed by the Australasian
Society of Clinical Immunology
and Allergy (ASCIA), Allergy &
Anaphylaxis Australia (A&AA), in
collaboration with key stakeholders.
CLICK HERE to access the strategy
document.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Aug 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Aug 15
